ZNTL- Zentalis Pharmaceuticals, Inc.

Name: Zentalis Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Zentalis Pharmaceuticals, Inc. (ZNTL) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 16 sells. ZNTL is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Walters Group	13.51M	$49.58M	-
10%	Matrix Capital Management Company, LP	6.46M	$23.71M	-
Other	Vultaggio Vincent	146.5K	$537.7K	-
Other	Bucher James B	100.0K	$367.0K	-
CEO	Eastland Julia Marie	79.1K	$290.4K	-

Activity

Buys and sells only

Transactions

10 filings · page 13

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 10, 2021	Bunker Kevin D.78	Chief Operating Officer	Sell	4,720	$45.24	$213,542.24	-7.4%	+23.1%	+2.1%
Mar 3, 2021	Bunker Kevin D.78	Chief Operating Officer	Sell	3,700	$45.07	$166,747.16	-5.5%	-	-
Mar 1, 2021	Bunker Kevin D.78	Chief Operating Officer	Sell	4,210	$41.65	$175,351.55	-5.9%	-	-
Mar 1, 2021	Sun Anthony Y81	President &CEO	Sell	26,794	$41.70	$1,117,224.54	-0.7%	-	-
Mar 1, 2021	Epperly Melissa B,72	Chief Financial Officer	Sell	3,083	$41.67	$128,482.48	-1.1%	-	-
Mar 1, 2021	Gallagher Cam81	Director	Sell	10,000	$41.69	$416,858.00	-1.7%	-	-
Feb 1, 2021	Sun Anthony Y81	President &CEO	Sell	26,794	$37.50	$1,004,837.46	-0.5%	-	-
Feb 1, 2021	Epperly Melissa B,72	Chief Financial Officer	Sell	3,083	$37.56	$115,804.67	-0.6%	-	-
Feb 1, 2021	Bunker Kevin D.78	Chief Operating Officer	Sell	4,210	$37.51	$157,918.32	-2.8%	-	-
Feb 1, 2021	Gallagher Cam81	Director	Sell	10,000	$37.49	$374,865.43	-0.9%	-	-

← PrevPage 13Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC